Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weichenthal

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Investigative Dermatology|March 24, 2007
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohortMichael Weichenthal, Andreas Ruether, Stefan Schreiber, et al.
Archives of Dermatological Research|January 13, 2006
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of associationStefan Jenisch, Jochen Hampe, James T Elder, et al.
The Journal of Investigative Dermatology|February 6, 2009
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactionsPaula Velasco, Rainer Huegel, Jochen Brasch, et al.
Melanoma Research|November 15, 2011
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trialMaja A Hofmann, Axel Hauschild, Peter Mohr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 16, 2013
Bacteriological pathogen spectrum of chronic leg ulcers: Results of a multicenter trial in dermatologic wound care centers differentiated by regionsFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Acta Dermato-Venereologica|February 24, 2022
Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONASMartin Kaatz, Peter Mohr, Elisabeth Livingstone, et al.
International Wound Journal|December 9, 2014
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in GermanyFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012Reinhard Dummer, Pietro Quaglino, Jürgen C Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasisAxel Hauschild, Michael Weichenthal, Bernd-Rudiger Balda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2016
S1-Guidelines on UV phototherapy and photochemotherapyThomas Herzinger, Mark Berneburg, Kamran Ghoreschi, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Investigative Dermatology|March 24, 2007
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohortMichael Weichenthal, Andreas Ruether, Stefan Schreiber, et al.
Archives of Dermatological Research|January 13, 2006
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of associationStefan Jenisch, Jochen Hampe, James T Elder, et al.
The Journal of Investigative Dermatology|February 6, 2009
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactionsPaula Velasco, Rainer Huegel, Jochen Brasch, et al.
Melanoma Research|November 15, 2011
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trialMaja A Hofmann, Axel Hauschild, Peter Mohr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 16, 2013
Bacteriological pathogen spectrum of chronic leg ulcers: Results of a multicenter trial in dermatologic wound care centers differentiated by regionsFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Acta Dermato-Venereologica|February 24, 2022
Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONASMartin Kaatz, Peter Mohr, Elisabeth Livingstone, et al.
International Wound Journal|December 9, 2014
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in GermanyFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012Reinhard Dummer, Pietro Quaglino, Jürgen C Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasisAxel Hauschild, Michael Weichenthal, Bernd-Rudiger Balda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2016
S1-Guidelines on UV phototherapy and photochemotherapyThomas Herzinger, Mark Berneburg, Kamran Ghoreschi, et al.
Pageof 17